Neutralizing/Blocking assay analysis of mouse skin endothelial cells (SENDs) treated with or without rat VEGFC (50ng/ml) in the absence or presence of 5 or 20 microg/ml GTX52393 VEGFC antibody for 30 mins. Phospho-VEGFR3 was detected with IP-Western for pTyrosine.
Neutralizing/Blocking assay analysis of mouse skin endothelial cells (SENDs) treated with or without rat VEGFC (50ng/ml) in the absence or presence of 5 or 20 microg/ml GTX52393 VEGFC antibody for 30 mins. Phospho-VEGFR3 was detected with IP-Western for pTyrosine.
VEGFC antibody
GTX52393
ApplicationsWestern Blot, Neutralisation/Blocking
Product group Antibodies
ReactivityMouse, Rat
TargetVegfc
Overview
- SupplierGeneTex
- Product NameVEGFC antibody - Orthogonal Validated
- Delivery Days Customer9
- ApplicationsWestern Blot, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID114111
- Target nameVegfc
- Target descriptionvascular endothelial growth factor C
- Target synonymsflt4 ligand; flt4-L; vascular endothelial growth factor C; vascular endothelial growth factor-related protein; VEGF-C; VRP
- HostRabbit
- IsotypeIgG
- Protein IDO35757
- Protein NameVascular endothelial growth factor C
- Scientific Descriptionplatelet-derived growth factor/vascular derived growth factor (PDGF/VEGF); active in angiogenesis and endothelial cell growth [RGD, Feb 2006]
- ReactivityMouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Impact of Lymphangiogenesis on Cardiac Remodeling After Ischemia and Reperfusion Injury. Shimizu Y et al., 2018 Oct 2, J Am Heart AssocRead more